2.500
+0,00%
2026-10-19
Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -10.4% | -5231.2% | 0 / 3 | -65.9% | +4.96 pp | -40.14 pp | -51.1% | 1.94 | — | 25,5 | −65,9% | −15,4 | −2,4% | — | -3.23 | — |
| Pts | 0 | 0 | 0 | 0 | 12 | 0 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 2.500 (close price on 2026-10-19)EPS (TTM): −1.746,9
Financial charts
1.Revenue & growth
VND bn25,5Q2/26
1.Revenue & growth
VND bn25,5Q2/26
2.Profit & growth
VND bn-16,0Q2/26
3.Profit mix (Penman)
VND bn-59,2Q2/26
4.Margins & cost structure
%1.6%Q2/26
5.Returns & cash cycle
% · days-3.1%Q2/26
6.Earnings quality & cash
VND bn10,3Q2/26
7.Asset structure
VND bn869Q2/26
8.Funding & debt health
VND bn · times869Q2/26
9.Revenue backlog
VND bn11,4Q2/26
10.Valuation
times · %-1,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-458Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-15679%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26